How are CYP2D6 and gut health related?

The direct relationship between CYP2D6 and gut health is not well established in current evidence. CYP2D6 is a liver enzyme primarily involved in metabolizing many drugs (e.g., antidepressants, beta-blockers). Gut health encompasses microbiome composition, barrier integrity, and immune function. Emerging research suggests the gut microbiome can modulate CYP enzyme activity through metabolites or inflammatory signals, but specific studies on CYP2D6 are limited and mostly preclinical. Some work indicates that certain gut bacteria may influence drug metabolism, but clinical relevance for gut health remains unclear. Consumer DNA tests often include CYP2D6 variants for drug response predictions, not for gut health. Therefore, evidence is best classified as 'mechanistic/unclear'. Users should not infer gut health status from CYP2D6 variants. For digestive issues, validated approaches like stool analysis, endoscopy, and a balanced diet with pre- and probiotics are more appropriate.